Klingman & Associates, LLC Merck & Co., Inc. Transaction History

Klingman & Associates, LLC

$1.61 Billion
Q3 2024

A detailed history of Klingman & Associates, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Klingman & Associates, LLC holds 9,510 shares of MRK stock, worth $932,455. This represents 0.07% of its overall portfolio holdings.

Number of Shares

9,510

Previous 9,594 0.88%

Holding current value

$932,455

Previous $1.19 Million 9.1%

% of portfolio

0.07%

Previous 0.08%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 01, 2024	SELL	$111.15 - $128.97 $9,336 - $10,833	-84 Reduced 0.88%	9,510 $1.08 Million
Q2 2024 Jul 30, 2024	BUY	$123.8 - $132.96 $85,917 - $92,274	694 Added 7.8%	9,594 $1.19 Million
Q1 2024 May 01, 2024	BUY	$113.24 - $131.95 $1,245 - $1,451	11 Added 0.12%	8,900 $1.17 Million
Q4 2023 Jan 29, 2024	SELL	$100.18 - $109.02 $987,674 - $1.07 Million	-9,859 Reduced 52.59%	8,889 $969,000
Q3 2023 Oct 30, 2023	BUY	$102.95 - $114.33 $315,850 - $350,764	3,068 Added 19.57%	18,748 $1.93 Million
Q2 2023 Jul 31, 2023	BUY	$108.61 - $118.38 $4,561 - $4,971	42 Added 0.27%	15,680 $1.81 Million
Q1 2023 May 03, 2023	SELL	$102.94 - $114.86 $8,132 - $9,073	-79 Reduced 0.5%	15,638 $1.66 Million
Q4 2022 Feb 03, 2023	SELL	$87.44 - $112.11 $25,007 - $32,063	-286 Reduced 1.79%	15,717 $1.74 Million
Q3 2022 Oct 28, 2022	SELL	$84.53 - $94.96 $7,776 - $8,736	-92 Reduced 0.57%	16,003 $1.38 Million
Q2 2022 Jul 27, 2022	SELL	$83.49 - $94.64 $1,669 - $1,892	-20 Reduced 0.12%	16,095 $1.47 Million
Q1 2022 May 06, 2022	BUY	$73.51 - $82.4 $28,448 - $31,888	387 Added 2.46%	16,115 $1.32 Million
Q4 2021 Jan 31, 2022	SELL	$72.28 - $90.54 $34,260 - $42,915	-474 Reduced 2.93%	15,728 $1.21 Million
Q3 2021 Nov 01, 2021	BUY	$71.68 - $78.83 $441,333 - $485,356	6,157 Added 61.29%	16,202 $1.22 Million
Q2 2021 Jul 27, 2021	BUY	$70.31 - $77.77 $311,754 - $344,832	4,434 Added 79.02%	10,045 $781,000
Q1 2021 Apr 29, 2021	SELL	$68.86 - $81.11 $12,188 - $14,356	-177 Reduced 3.06%	5,611 $433,000
Q4 2020 Feb 09, 2021	BUY	$71.77 - $79.65 $58,564 - $64,994	816 Added 16.41%	5,788 $473,000
Q3 2020 Nov 03, 2020	BUY	$73.18 - $82.95 $50,860 - $57,650	695 Added 16.25%	4,972 $412,000
Q2 2020 Aug 04, 2020	SELL	$70.42 - $80.13 $5,211 - $5,929	-74 Reduced 1.7%	4,277 $331,000
Q1 2020 Apr 29, 2020	BUY	$63.36 - $87.82 $31,553 - $43,734	498 Added 12.92%	4,351 $335,000
Q4 2019 Jan 29, 2020	BUY	$77.58 - $87.54 $2,870 - $3,238	37 Added 0.97%	3,853 $350,000
Q3 2019 Oct 22, 2019	SELL	$76.08 - $82.93 $6,618 - $7,214	-87 Reduced 2.23%	3,816 $321,000
Q2 2019 Sep 27, 2019	BUY	$69.84 - $81.59 $272,585 - $318,445	3,903 New	3,903 $327,000
Q2 2019 Jul 24, 2019	SELL	$69.84 - $81.59 $280,477 - $327,665	-4,016 Closed	0 $0
Q4 2018 Jan 28, 2019	SELL	$65.24 - $75.71 $76,200 - $88,429	-1,168 Reduced 22.53%	4,016 $307,000
Q2 2018 Aug 02, 2018	BUY	$50.83 - $59.72 $60,996 - $71,664	1,200 Added 30.12%	5,184 $315,000
Q3 2017 Oct 24, 2017	BUY	$58.67 - $63.13 $233,741 - $251,509	3,984	3,984 $255,000

Others Institutions Holding MRK

# of Institutions

3,827

Shares Held

1.87B

Call Options Held

15.6M

Put Options Held

13.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $248B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Klingman & Associates, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Klingman & Associates, LLC with notifications on news.

Account

Klingman & Associates, LLC Merck & Co., Inc. Transaction History